Cancer Health Treatment Update Libtayo Immunotherapy OK'd for More Lung Cancer Patients The checkpoint inhibitor is now approved for people with advanced non-small-cell lung cancer regardless of PD-L1 biomarker levels. When Cancer Screenings Are Free but Follow-ups Aren’t, Patients Foot the Bill Plus, a court ruling has the potential to invalidate required free screenings, including for breast, colorectal, cervical and lung cancer. Evidence for “Tough Conversations” Around Racism in Access to Cancer Care Black patients with ovarian cancer were less likely than white counterparts to be treated according to NCCN guidelines, a new study shows. Sexuality: A Human Right for People With Cancer Just as we address quality of life, we should strive for a better sexual life for all people with cancer, says Don Dizon, MD, who runs a sexuality clinic for people with cancer. News from the ESMO Congress See all reports from Europe's largest cancer conference. Advertisement Cancer Health now offers individual newsletters for people interested in specific cancer types. Get the latest cancer news tailored to your needs and interests delivered to your inbox. To update your preferences and start getting cancer-specific newsletters, please visit your personal preferences page. People With Long COVID Face Barriers to Government Disability Benefits Many people with long COVID are falling through the cracks of a system that was difficult to navigate even before the pandemic.  More News About COVID-19 See all Cancer Health's coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Fall 2022 Check out our latest print edition! Newsfeed American Cancer Society Responds to NEJM Colonoscopy Study Evidence for “Tough Conversations” Around Racism in Access to Cancer Care Court Ruling May Spur Competitive Health Plans to Bring Back Copays for Preventive Services Carly Simon Honors Sisters Who Died of Cancer Just One Day Apart [VIDEO] Blog: National Cancer Institute Is a Genomic Test Better at Finding Aggressive Prostate Cancer? Tecvayli Shows Promise for People with Heavily Pretreated Multiple Myeloma Immunotherapy Before Surgery Appears Effective for Some with Melanoma FDA OKs Drug to Reduce Hearing Loss in Kids With Cancer Newsfeed American Cancer Society Responds to NEJM Colonoscopy Study Evidence for “Tough Conversations” Around Racism in Access to Cancer Care Court Ruling May Spur Competitive Health Plans to Bring Back Copays for Preventive Services Carly Simon Honors Sisters Who Died of Cancer Just One Day Apart [VIDEO] Blog: National Cancer Institute Is a Genomic Test Better at Finding Aggressive Prostate Cancer? Tecvayli Shows Promise for People with Heavily Pretreated Multiple Myeloma Immunotherapy Before Surgery Appears Effective for Some with Melanoma FDA OKs Drug to Reduce Hearing Loss in Kids With Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: